SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Daniel J. Buzard, Luis Lopez, Jeanne Moody, Andrew Kawasaki, Thomas O. Schrader, Michelle Kasem, Ben Johnson, Xiuwen Zhu, Lars Thoresen, Sun Hee Kim, Tawfik Gharbaoui, Dipanjan Sengupta, Lorene Calvano, Ashwin Krishnan, Yinghong Gao, Graeme Semple, Jeff Edwards, Jeremy Barden, Michael Morgan, Khawja Usmani, Chuan Chen, Abu Sadeque, Weichao Chen, Ronald J. Christopher, Jayant Thatte, Lixia Fu, Michelle Solomon, Kevin Whelan, Hussien Al-Shamma, Joel Gatlin, Ibragim Gaidarov, Todd Anthony, Minh Le, David J. Unett, Scott Stirn, Anthony Blackburn, Dominic P. Behan, Robert M. Jones, (7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic Acids as S1P1Functional Antagonists, ACS Medicinal Chemistry Letters, 2014, 5, 12, 1334

    CrossRef

  2. 2
    Jing Jin, Jinping Hu, Wanqi Zhou, Xiaojian Wang, Qiong Xiao, Nina Xue, Dali Yin, Xiaoguang Chen, Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis, Biochemical Pharmacology, 2014, 90, 1, 50

    CrossRef

  3. 3
    Martin H. Bolli, Stefan Abele, Magdalena Birker, Roberto Bravo, Daniel Bur, Ruben de Kanter, Christopher Kohl, Julien Grimont, Patrick Hess, Cyrille Lescop, Boris Mathys, Claus Müller, Oliver Nayler, Markus Rey, Michael Scherz, Gunther Schmidt, Jürgen Seifert, Beat Steiner, Jörg Velker, Thomas Weller, Novel S1P1Receptor Agonists − Part 3: From Thiophenes to Pyridines, Journal of Medicinal Chemistry, 2014, 57, 1, 110

    CrossRef

  4. 4
    François Curtin, Hans-Peter Hartung, Novel therapeutic options for multiple sclerosis, Expert Review of Clinical Pharmacology, 2014, 7, 1, 91

    CrossRef

  5. 5
    Marc Bigaud, Danilo Guerini, Andreas Billich, Frederic Bassilana, Volker Brinkmann, Second generation S1P pathway modulators: Research strategies and clinical developments, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014, 1841, 5, 745

    CrossRef

  6. 6
    Julia K. Archbold, Jennifer L. Martin, Matthew J. Sweet, Towards selective lysophospholipid GPCR modulators, Trends in Pharmacological Sciences, 2014, 35, 5, 219

    CrossRef

  7. 7
    Rehiana Ali, Richard St John Nicholas, Paolo Antonio Muraro, Drugs in Development for Relapsing Multiple Sclerosis, Drugs, 2013, 73, 7, 625

    CrossRef

  8. 8
    Gregory T. Kunkel, Michael Maceyka, Sheldon Milstien, Sarah Spiegel, Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond, Nature Reviews Drug Discovery, 2013, 12, 9, 688

    CrossRef